In the mammary gland, large quantities of membrane-associated protein are discharged from the apical surface of secretory cells into milk in the form of fat-globule membrane (Anderson & Cawston, 1975; Patton & Keenan, 1975) . Recent evidence suggests that some of these membrane proteins possess antigenic determinants unique to mammary secretory cells (Ceriani et al., 1977 (Ceriani et al., , 1978 . As a consequence, specific antibodies to these proteins are potentially valuable markers of secretory cells and both the plasma membrane and endomembranes of these cells. Some of the proteins of fat-globule membrane are also expressed on the surface of mammary-tumour-cell lines, which raises the possibility of isolating tumour-specific antibodies by using fat-globule-membrane proteins as immunogens (Ceriani et al., 1977 (Ceriani et al., , 1978 .
Antisera prepared by conventional methods, however, often lack specificity, and non-specific antibodies have to be removed by adsorption on to appropriate immobilized antigens. Since the work of K6hler & Milstein (1975 K6hler & Milstein ( , 1976 
Methods
Immunization of mice. Fat-globule-membrane was prepared from bovine milk as described by Mather (1978 Hvbridization and culturing techniques, and collection of antisera. Spleen cells (6 x 108) from immunized mice were fused with SP-2/0 cells (6 x 10') essentially as described by Goldsby et al. (1977) . After fusion the cells were diluted in the HAT (hypoxanthine/aminopterin/thymidine) medium of Littlefield (1964) and distributed in 0.1 ml aliquots to the wells of 96-well microtitre plates with the aid of a mechanical cloning and sampling apparatus of the type described by Goldsby & Mandell (1973) . The first hybrid clones appeared 12 days after fusion. Selected hybrid clones elaborating antibody to fat-globule mem-0306-3283/80/060925-04$01.50/1 ©) 1980 The Biochemical Society brane were re-cloned by limiting dilution as outlined by Goldsby & Zipser (1969) .
Antibody-secreting tumours were produced by subcutaneous inoculation of 3-5-month-old Balb/cJ mice with approx. 5 x 106 hybrid cells. Animals were tail-bled when tumours became palpable and exsanguinated between 3-5 days later. The tumours were removed, minced, a portion passaged in 3-5-month-old Balb/cJ recipients, and the remainder frozen in liquid N2.
Radioirnrnunoassa'v. Antibody to fat-globule membrane and purified xanthine oxidase was detected by a solid-phase radioimmunoassay based on the procedure of Rosenthal et al. (1973) . An 1251_ labelled rabbit antibody to mouse immunoglobulins (IgA, IgG1, IgG2., IgG2b, and IgM) that had been purified by adsorption to a mouse immunoglobulin affinity column was used as a detecting agent.
Preparation of xanthine oxidase. Xanthine oxidase was purified by extracting washed fat-globules with butan-1-ol as described by Waud et al. (1975) fat-globule membrane (Fig. la) . Of these positive clones, 47 were re-tested for the production of antibody to unfractionated fat-globule membrane and additionally tested against purified xanthine oxidase. Of the twelve clones retained, nine were still positive for monoclonal-antibody production after re-cloning and growth in culture (Fig. lb) . Clones 94. 113, 155 and 166 secreted antibody that bound to purified xanthine oxidase.
All nine hybrids were successfully transplanted as solid tumours in Balb/cJ mice. Fig. 2 compares the results of titrating the plasma of mice carrying clones 166 and 42 with control plasma obtained from tumour-free mice. Monoclonal antibody could be detected in the plasma from tumour-bearing mice down to a dilution of 1:256000. Plasma containing monoclonal antibody had only a slightly greater tendency to bind to an unrelated antigen (rabbit erythrocyte 'ghosts') than did plasma from control mice. Results were essentially similar with all nine cell lines, and the specificity for xar.1hine oxidase was retained by four hybrids as in Fig. (b) .
Discussion
Antibodies to proteins of mouse, bovine and human milk-fat-globule membrane have been prepared previously in several species by using conventional procedures (e.g. Ceriani et al., 1977 Ceriani et al., , 1978 Kanno & Yamauchi, 1978 : Nielsen & Bjerrum. 1977 : Freudenstein et al., 1979 . Such antibody has been used for a number of purposes, including the analysis and comparison of fat-globule-membrane proteins by immunological procedures (Nielsen & Bjerrum, 1977; Freudenstein et al.. 1979) . the identification of mammary secretory cells and certain mammary-tumour-cell lines by immunofluorescence microscopy (Ceriani et al., 1977 (Ceriani et al., , 1978 , and determination of the distribution of membrane antigens in mammary tissue (Freudenstein et al., 1979) . It has also been suggested that specific antibodies to fat-globule-membrane proteins may be used to monitor the spread of malignant tumours and act as carriers of cytotoxic agents to the surfaces of tumour cells in breast-cancer patients (Ceriani et al., 1977) .
The demonstration that hybridomas can be isolated that secrete monoclonal antibody to proteins of fat-globule membrane is therefore of general significance, because the success of the above procedures is largely dependent on the preparation of antibody of rigorously defined specificity. The methods we have used permit the use of unfractionated fat-globule membrane as an immunogen for preparing highly specific antibody to individual membrane proteins. Since fat-globule membrane can be easily isolated from the milk of many species, it will therefore be possible to prepare specific antibody to a number of physiologically important proteins without initially having to purify the individual antigens.
The demonstration that four of the nine hybridomas isolated secrete antibody specific for xanthine oxidase is specially noteworthy. This protein is present in large quantities in milk and has been purified by several procedures, some of which have involved the use of proteinases (e.g. Gilbert & Bergel, 1964) . The solubilization of xanthine oxidase by proteolysis has led to erroneous estimations of its molecular weight, and there has therefore been some controversy about the size of the native form of this enzyme (Waud et al., 1975; Mangino & Brunner, 1977) .
There is also little known about the function of xanthine oxidase in mammary tissue. Recent work suggests that the enzyme forms part of the innerVol. 188 (Mather & Keenan, 1975; Nielsen & Bjerrum, 1977; Freudenstein et al., 1979) , and may catalyse the formation of superoxide at the cell surface (Low & Crane, 1978) .
The preparation of monoclonal antibodies to xanthine oxidase will provide new probes for estimating the size and determining the function of this enzyme in mammary tissue. Thus chromatography of solubilized xanthine oxidase from mammary tissue or milk by using monoclonal antibody immobilized on Sepharose should allow the preparation of the enzyme in its undegraded form. By using radioimmunoassays and immunocytochemical procedures it should also be possible to determine the distribution of xanthine oxidase in milk and in mammary tissue. Knowledge of the location of xanthine oxidase in mammary secretory cells may well prove to be the key to understanding the function of this enzyme at the cellular level.
